No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 31, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Among the Worst Performing Stocks in S&P 500 So Far in 2025

by TheAdviserMagazine
6 months ago
in Business
Reading Time: 5 mins read
A A
Among the Worst Performing Stocks in S&P 500 So Far in 2025
Share on FacebookShare on TwitterShare on LInkedIn


We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other worst performing stocks this year.

After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs, resulting in a year-to-date decline of nearly 6%.

READ ALSO: 11 Most Promising Stocks According to Analysts and 15 Best Dividend Stocks to Buy for Long-Term Passive Income.

Trends over the past century have shown that sustained high returns are uncommon. Following the strong back-to-back performance in the 1920s, markets fell sharply in 1929, which marked the beginning of the Great Depression. Then, after recovering in 1935 and 1936, it took a giant step back again a year later.

A recent report by a leading investment banking company also pointed out how, historically, bull markets produce mediocre returns in the third year. Although they are usually not negative. The New York-based firm has projected positive but muted returns for 2025, while also noting that the continued adoption of artificial intelligence has the potential to lead to a productivity boom and a stronger market rally.

The broad market index ended 0.74% higher on April 24, gaining 4.6% for the week, driven by a rebound in tech shares. The US Dollar also had its first weekly rise since March, as investors looked for signs that the ongoing trade war may be easing.

Washington also appears to have softened its stance on trade relations with Beijing. In an interview with Time magazine on April 22, Trump stated his administration was engaged with China on striking a tariff deal. The US president also expects announcements on many other trade deals to be made over the next three to four weeks.

While talking to CNBC, Jay Hatfield, founder and chief investment officer of InfraCap, expressed optimism that the worst of the uncertainty around tariffs is over:

“The confusion about whether there’s really talks going on with China or not took some steam out of the market. Our view is that we’ve reached peak tariff tantrum and so it’s likely to be more positive than negative.”

Chip Rewey, CIO of Rewey Asset Management, said the following on the situation by Reuters:

“This week you’ve seen kind of relief that maybe some of the worst case of the Trump tariff actions won’t come true. While we’ve recovered from some of the lows, we haven’t pushed back to highs. And I think somewhere in that range is where we’ll stay for a while.”

Story Continues

With that said, let’s now head over to discuss the worst performing stocks this year.

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

A laboratory scientist surrounded by drug-discovery equipment and resources.

For this article, we went through screeners to identify stocks listed on the S&P index. From there, we picked the top 11 stocks with the worst year-to-date negative returns in share price, as of the close of business on Friday, April 25, 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

YTD Decline in Share Price: -37.22%

Charles River Laboratories International, Inc. (NYSE:CRL) is a drug development company that provides essential products and services to help pharmaceutical and biotech companies, academic institutions, and government agencies worldwide accelerate their R&D efforts.

It is among the worst performing stocks this year. The company’s shares have slumped this month after the FDA announced plans to replace animal testing for monoclonal antibody therapies and other drugs with more effective methods, such as AI-based models. The decision has come as a huge blow to Charles River Laboratories International, Inc. (NYSE:CRL), which is heavily reliant on animal-based preclinical research.

Shortly after the announcement, analysts adjusted their positions on Charles River Laboratories International, Inc. (NYSE:CRL). This included Mizuho, which lowered its price target to $155 per share from $175, and Barclays, which revised the target to $145 from $160. The consensus analyst rating for CRL is now Hold, reflecting the growing uncertainty around the company.

Upslope Capital Management stated the following regarding Charles River Laboratories International, Inc. (NYSE:CRL) in its Q1 2025 investor letter:

“Charles River Laboratories International, Inc. (NYSE:CRL) (CRL, testing, discovery, and safety for biopharma) – sold due to a thesis break when the FDA announced the phase-out of animal testing requirements for certain drugs. This was a risk I’d worried about, and given an already-challenging environment for the company I decided the thesis (cyclical bottom) had been broken.”

Charles River Laboratories International, Inc. (NYSE:CRL) is scheduled to announce financial results for the first quarter of fiscal 2025 on May 7. Based on the forecast of 8 analysts, the company is expected to report EPS of $2.06, down from $2.27 during the same period last year.

Overall, CRL ranks 3rd among the 11 Worst Performing Stocks in S&P 500 So Far in 2025. While we acknowledge the potential of CRL, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than CRL but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires

Disclosure: None. This article is originally published at Insider Monkey.



Source link

Tags: amongPerformingstocksWorst
ShareTweetShare
Previous Post

Trump Sets His Sights On International Lawyers – See Also

Next Post

Apple must halt non-app store sales commissions, judge says

Related Posts

edit post
Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

by TheAdviserMagazine
October 31, 2025
0

Bandhan Bank shares fell 5.9% to an intraday low of Rs 160.40 on BSE on Friday, October 31, after the...

edit post
Getting Started: Inventory Types and Conditions

Getting Started: Inventory Types and Conditions

by TheAdviserMagazine
October 31, 2025
0

Take the guesswork out of sourcing! We want you to make the most informed purchases possible. In order to do...

edit post
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

by TheAdviserMagazine
October 30, 2025
0

Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...

edit post
Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

by TheAdviserMagazine
October 30, 2025
0

US equity-index futures rose after strong earnings from Amazon.com Inc. and Apple Inc. spurred a post-market tech rally, lifting sentiment...

edit post
Michael Saylor’s Strategy returns to profitability in third quarter

Michael Saylor’s Strategy returns to profitability in third quarter

by TheAdviserMagazine
October 30, 2025
0

Bitcoin accumulator Strategy Inc. returned to profitability in the third quarter, with results bolstered by an unrealized gain tied to...

edit post
Planning approved for new Jerusalem luxury hotel

Planning approved for new Jerusalem luxury hotel

by TheAdviserMagazine
October 30, 2025
0

Building a hotel is an expensive business, but before you build you need a high-quality location. Pai Siam (TASE:...

Next Post
edit post
Apple must halt non-app store sales commissions, judge says

Apple must halt non-app store sales commissions, judge says

edit post
XRP traders predict new all-time highs as ETF approval odds rise to 85%

XRP traders predict new all-time highs as ETF approval odds rise to 85%

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Fed winding down balance sheet contraction amid tightening money markets

Fed winding down balance sheet contraction amid tightening money markets

0
edit post
Breast cancer drug stock Olema could more than double from here, analysts say

Breast cancer drug stock Olema could more than double from here, analysts say

0
edit post
Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

0
edit post
Book Review: Resistance Money: A Philosophical Case for Bitcoin

Book Review: Resistance Money: A Philosophical Case for Bitcoin

0
edit post
ECB October 2025 rate decision

ECB October 2025 rate decision

0
edit post
Goldman Sachs survey says only 11% of companies are actively linking layoffs to AI—but the real shock is yet to come

Goldman Sachs survey says only 11% of companies are actively linking layoffs to AI—but the real shock is yet to come

0
edit post
How to protect your bank account

How to protect your bank account

October 31, 2025
edit post
Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore

October 31, 2025
edit post
Getting Started: Inventory Types and Conditions

Getting Started: Inventory Types and Conditions

October 31, 2025
edit post
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results (NASDAQ:BIIB)

October 30, 2025
edit post
Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

Asian shares rise: Asian shares, US futures rise on tech results, gold holds gain

October 30, 2025
edit post
XRP Could Drive the ‘Biggest Economic Shift’ in Decades: Crypto Expert

XRP Could Drive the ‘Biggest Economic Shift’ in Decades: Crypto Expert

October 30, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • How to protect your bank account
  • Bandhan Bank shares fall 6% after Q2 PAT plunges 88% YoY to Rs 110 crore
  • Getting Started: Inventory Types and Conditions
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.